Keyword: South Korea

Sun Pharma drops to six-year low; Takeda looks to sell emerging markets products; Immunochina raises $20 million for CAR-T push.

Samsung is fighting back against charges that it improperly changed the method by which it valued a joint venture with Biogen.

Samsung BioLogics faces potential delisting; Merck will increase Gardasil supply to China; Chinese officials mulls new regulation for vaccine.

Korean securities watchdog has requested to review whether the company should be delisted and recommended the dismissal of its CEO.

Novo said it cracked down on the wholesaler through its local distributor Zuellig Pharma Korea, which terminated the alleged smuggler’s contract.

Opdivo is priced in China at half its U.S. cost; Novartis names new chief for scandal-hit Korea unit; GSK's Indian consumer unit attracts new buyers.

An ongoing criminal trial in Korea alleges that Novartis used medical journals to funnel kickbacks to doctors.

Multinational pharma companies have all together closed 16 manufacturing plants in South Korea over the past 20 years, local media reports.

South Korea's PRP has acquires a 6,000 meter plant that can produce 2 million vials of the generic ingredient used in wrinkle fighter Botox.

It's believed that SK Chemicals is stealing shingles vaccine share from Zostavax by undercutting the pharma giant's price.